Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity
Piaopiao Li, Jithin Sam Varghese, Megha Shah, Rodolfo J. Galindo, Francisco J. Pasquel, Mohammed K. Ali, Hui Shao
Abstract
This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity.
Topics & Concepts
MedicineType 2 diabetesObesityReceptorDiabetes mellitusAgonistInternal medicineGlucagon-like peptide 1 receptorEndocrinologyType 1 diabetesPeptidePharmacologyC-peptideType 2 Diabetes MellitusLeptin receptorBioinformaticsDrugDiabetes Treatment and ManagementBariatric Surgery and OutcomesDiabetes Management and Research